356 related articles for article (PubMed ID: 29653579)
1. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
Tong WY; Alnakhli M; Bhardwaj R; Apostolou S; Sinha S; Fraser C; Kuchel T; Kuss B; Voelcker NH
J Nanobiotechnology; 2018 Apr; 16(1):38. PubMed ID: 29653579
[TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles.
Hasanzadeh Kafshgari M; Alnakhli M; Delalat B; Apostolou S; Harding FJ; Mäkilä E; Salonen JJ; Kuss BJ; Voelcker NH
Biomater Sci; 2015 Dec; 3(12):1555-65. PubMed ID: 26343506
[TBL] [Abstract][Full Text] [Related]
3. Cancer-targeting siRNA delivery from porous silicon nanoparticles.
Wan Y; Apostolou S; Dronov R; Kuss B; Voelcker NH
Nanomedicine (Lond); 2014 Oct; 9(15):2309-21. PubMed ID: 24593001
[TBL] [Abstract][Full Text] [Related]
4. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
5. PEI-Coated Fe₃O₄ Nanoparticles Enable Efficient Delivery of Therapeutic siRNA Targeting REST into Glioblastoma Cells.
Wang R; Degirmenci V; Xin H; Li Y; Wang L; Chen J; Hu X; Zhang D
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065155
[TBL] [Abstract][Full Text] [Related]
6. Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin.
Tieu T; Wojnilowicz M; Huda P; Thurecht KJ; Thissen H; Voelcker NH; Cifuentes-Rius A
Biomater Sci; 2021 Jan; 9(1):133-147. PubMed ID: 33135714
[TBL] [Abstract][Full Text] [Related]
7. Down-Regulation of MRP1 Expression in C6/VP16 Cells by Chitosan-MRP1-siRNA Nanoparticles.
Xu H; Nie X; Wu L; Zhu X; Yi W; Huang S
Cell Biochem Biophys; 2015 May; 72(1):227-33. PubMed ID: 25543328
[TBL] [Abstract][Full Text] [Related]
8. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells.
Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B
Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608
[TBL] [Abstract][Full Text] [Related]
9. SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA expression.
Yuan H; Huang X; Li Q; Luo C; Lin C; Zhang S; Zhang Y; Yan Z; Du N; Liu Z; Jiang H; Chen B
Biomed Pharmacother; 2022 Mar; 147():112672. PubMed ID: 35104698
[TBL] [Abstract][Full Text] [Related]
10. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
11. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
12. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
13. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP
Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511
[TBL] [Abstract][Full Text] [Related]
14. Polyethylenimine-Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells.
Melamed JR; Ioele SA; Hannum AJ; Ullman VM; Day ES
Mol Pharm; 2018 Nov; 15(11):5135-5145. PubMed ID: 30260647
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of therapeutic siRNA into glioblastoma cells.
Kong L; Qiu J; Sun W; Yang J; Shen M; Wang L; Shi X
Biomater Sci; 2017 Jan; 5(2):258-266. PubMed ID: 27921110
[TBL] [Abstract][Full Text] [Related]
16. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
[TBL] [Abstract][Full Text] [Related]
17. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
[TBL] [Abstract][Full Text] [Related]
18. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J
Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738
[TBL] [Abstract][Full Text] [Related]
19. Chemoresistance in high-grade gliomas: relevance of adenosine signalling in stem-like cells of glioblastoma multiforme.
Garrido W; Rocha JD; Jaramillo C; Fernandez K; Oyarzun C; San Martin R; Quezada C
Curr Drug Targets; 2014; 15(10):931-42. PubMed ID: 25174341
[TBL] [Abstract][Full Text] [Related]
20. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]